Skip to Main Content

Paper Details

Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers.
Am Heart J
42
2019
CAD, CVD, HIV, NCP, PWH, People, Statin, cardiovascular disease, cardiovascular events, coronary artery disease, coronary atherosclerosis, inflammation, noncalcified coronary atherosclerotic plaque, participant, participants, pitavastatin, pitavastatin calcium
Author NameAffiliation
Carl J FichtenbaumUniversity of Cincinnati College of Medicine
Tricia H BurdoTemple University School of Medicine
Heather J RibaudoCenter for Biostatistics in AIDS Research, Harvard TH Chan School of Public Health
Pamela S DouglasDuke Clinical Research Institute, Duke University School of Medicine
  • 1 - 4

Datasets

Release 1.2